MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner.
暂无分享,去创建一个
[1] J. Kwon. Improving survival after endometrial cancer: the big picture , 2015, Journal of gynecologic oncology.
[2] H. Gabra,et al. The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future. , 2014, British medical bulletin.
[3] Zu-jing Yang,et al. MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1 , 2014, PloS one.
[4] Xinru Wang,et al. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. , 2014, Cellular signalling.
[5] Li Zhou,et al. MicroRNA‐23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt‐related transcription factor‐2 , 2014, FEBS letters.
[6] Q. Cao,et al. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. , 2014, International journal of clinical and experimental pathology.
[7] S. Shen,et al. MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer , 2014, Clinical and Translational Oncology.
[8] Jin Cao,et al. miR-335 represents an independent prognostic marker in epithelial ovarian cancer. , 2014, American journal of clinical pathology.
[9] Annette Lee,et al. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes , 2013, British Journal of Cancer.
[10] E. Amankwah,et al. Global ovarian cancer health disparities. , 2013, Gynecologic oncology.
[11] Yuan-li He,et al. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer , 2012, Oncology reports.
[12] Hiroshi Kobayashi,et al. Molecular genetics and epidemiology of epithelial ovarian cancer (Review). , 2011, Oncology reports.
[13] D. Armstrong,et al. Recent progress in the diagnosis and treatment of ovarian cancer , 2011, CA: a cancer journal for clinicians.
[14] Subbaya Subramanian,et al. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.
[15] Xiaofei Zheng,et al. miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells , 2010, BMC Cancer.
[16] Israel Steinfeld,et al. Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types , 2009, PloS one.
[17] T. Liang,et al. The emerging role of microRNAs in immune cell development and differentiation , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[18] E. Miska,et al. How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.
[19] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[20] C. Croce,et al. MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.